Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer
Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer
The aim of this work was to investigate radiomic analysis of contrast and non-contrast enhanced planning CT images of oesophageal cancer (OC) patients in terms of stability, dimensionality and contrast agent dependency. The prognostic significance of CT-based radiomic features was also evaluated. Different 2D and 3D radiomic features were extracted from contrast and non-contrast enhanced CT images of 213 patients from the multi-centre SCOPE1 randomised controlled trial (RCT) in OC. Feature stability was evaluated by randomly dividing patients into three groups and identifying textures with similar distributions among groups with a Kruskal-Wallis analysis. A paired two-sided Wilcoxon signed rank test was used to assess for significant differences in the remaining corresponding 2D and 3D stable features. A prognostic model was constructed using clinical characteristics and remaining filtered features. The discriminative ability of significant variables was tested using Kaplan-Meier analysis. A total of 238 2D and 3D radiomic features were computed from oesophageal CT images. More than 75 features were stable if extracted from homogeneous cohort (contrast or non-contrast enhanced CT images) and inhomogeneous cohort (contrast and non-contrast enhanced CT images). Among the remaining corresponding stable features computed from both cohorts, only 4 features did not show a statistically significant difference if obtained in 2D or in 3D (p-value < 0.05). A Cox regression model constructed using 5 clinical variables (age, sex, tumour, node and metastasis (TNM) stage, WHO performance status and contrast administration) and 4 radiomic variables (inverse varianceGLCM, large distance emphasisGLDZM, zone distance non uniformity normGLDZM, zone distance varianceGLDZM), identified one radiomic feature (zone distance varianceGLDZM) that was significantly associated with overall survival (p-value = 0.032, HR = 1.25, 95% CI = 1.02–1.52). A significant difference in overall survival between groups was found when considering a threshold of zone distance varianceGLDZM equals to 1.70 (X2 = 7.692, df = 1, p-value = 0.006). Zone distance varianceGLDZM was identified as the only stable CT radiomic feature statistically correlated with overall survival, independent of dimensionality and contrast administration. This feature was able to identify high-risk patients and if validated, could be the subject of a future clinical trial aiming to improve clinical decision making and personalise OC treatment.
Piazzese, Concetta
5c97a75c-4b7e-41f1-b3d8-0dae88bffa0e
Foley, Kieran
44772d9c-2bfe-469d-a578-d9a96823cac3
Whybra, Philip
f0629d2b-8f2a-4ca5-b853-f667ef0b8dc8
Hurt, Chris
bf8b37a0-8f08-4b47-b3f3-6fc65f7ab87f
Crosby, Tom
ca225e45-0d13-4515-8c8a-e505d354dd0a
Spezi, Emiliano
b766d5e8-da6f-44ea-bc65-583781bbb445
22 November 2019
Piazzese, Concetta
5c97a75c-4b7e-41f1-b3d8-0dae88bffa0e
Foley, Kieran
44772d9c-2bfe-469d-a578-d9a96823cac3
Whybra, Philip
f0629d2b-8f2a-4ca5-b853-f667ef0b8dc8
Hurt, Chris
bf8b37a0-8f08-4b47-b3f3-6fc65f7ab87f
Crosby, Tom
ca225e45-0d13-4515-8c8a-e505d354dd0a
Spezi, Emiliano
b766d5e8-da6f-44ea-bc65-583781bbb445
Piazzese, Concetta, Foley, Kieran, Whybra, Philip, Hurt, Chris, Crosby, Tom and Spezi, Emiliano
(2019)
Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer.
PLoS ONE, 14 (11), [e0225550].
(doi:10.1371/journal.pone.0225550).
Abstract
The aim of this work was to investigate radiomic analysis of contrast and non-contrast enhanced planning CT images of oesophageal cancer (OC) patients in terms of stability, dimensionality and contrast agent dependency. The prognostic significance of CT-based radiomic features was also evaluated. Different 2D and 3D radiomic features were extracted from contrast and non-contrast enhanced CT images of 213 patients from the multi-centre SCOPE1 randomised controlled trial (RCT) in OC. Feature stability was evaluated by randomly dividing patients into three groups and identifying textures with similar distributions among groups with a Kruskal-Wallis analysis. A paired two-sided Wilcoxon signed rank test was used to assess for significant differences in the remaining corresponding 2D and 3D stable features. A prognostic model was constructed using clinical characteristics and remaining filtered features. The discriminative ability of significant variables was tested using Kaplan-Meier analysis. A total of 238 2D and 3D radiomic features were computed from oesophageal CT images. More than 75 features were stable if extracted from homogeneous cohort (contrast or non-contrast enhanced CT images) and inhomogeneous cohort (contrast and non-contrast enhanced CT images). Among the remaining corresponding stable features computed from both cohorts, only 4 features did not show a statistically significant difference if obtained in 2D or in 3D (p-value < 0.05). A Cox regression model constructed using 5 clinical variables (age, sex, tumour, node and metastasis (TNM) stage, WHO performance status and contrast administration) and 4 radiomic variables (inverse varianceGLCM, large distance emphasisGLDZM, zone distance non uniformity normGLDZM, zone distance varianceGLDZM), identified one radiomic feature (zone distance varianceGLDZM) that was significantly associated with overall survival (p-value = 0.032, HR = 1.25, 95% CI = 1.02–1.52). A significant difference in overall survival between groups was found when considering a threshold of zone distance varianceGLDZM equals to 1.70 (X2 = 7.692, df = 1, p-value = 0.006). Zone distance varianceGLDZM was identified as the only stable CT radiomic feature statistically correlated with overall survival, independent of dimensionality and contrast administration. This feature was able to identify high-risk patients and if validated, could be the subject of a future clinical trial aiming to improve clinical decision making and personalise OC treatment.
Text
file (5)
- Version of Record
More information
Accepted/In Press date: 6 November 2019
Published date: 22 November 2019
Identifiers
Local EPrints ID: 488209
URI: http://eprints.soton.ac.uk/id/eprint/488209
ISSN: 1932-6203
PURE UUID: 03c960af-f8ed-4a0a-9254-cd4e9bb7a7ae
Catalogue record
Date deposited: 18 Mar 2024 17:53
Last modified: 23 Mar 2024 03:13
Export record
Altmetrics
Contributors
Author:
Concetta Piazzese
Author:
Kieran Foley
Author:
Philip Whybra
Author:
Chris Hurt
Author:
Tom Crosby
Author:
Emiliano Spezi
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics